Importantly, the analysis of IFN-γ responses in PBMCs isolated from the different groups demonstrated no effect of anti PD-1 therapy on the magnitude of h5T4-specific T cell responses in circulation, suggesting that anti PD-1 antibodies are acting at the tumour site (Figure 5C). Here, IFNG is linked to neoplasm.